Physician profile
Karin Damico
NPI 1033145891
$1,136.01
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.82 · 2022: $395 · 2023: $451 · 2024: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $321.57 | 2021-2024 | Wegovy, Saxenda |
| Abbott Laboratories | $149.35 | 2021-2024 | Freestyle Libre 3 |
| Dexcom, INC. | $119.40 | 2023-2024 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $67.85 | 2023-2024 | |
| Abbvie INC. | $59.80 | 2022-2024 | |
| Tolmar Pharmaceuticals, INC. | $51.10 | 2022 | |
| Amgen INC. | $43.25 | 2022-2024 | Prolia, Evenity |
| Xeris Pharmaceuticals, INC. | $38.77 | 2023 | Recorlev |
| Lilly USA, LLC | $31.90 | 2024 | Zepbound |
| Merck Sharp & Dohme LLC | $30.25 | 2021-2022 | |
| Insulet Corporation | $29.42 | 2022-2023 | Omnipod |
| Tolmar, INC. | $24.88 | 2023 | |
| Ascensia Diabetes Care US INC. | $24.25 | 2023 | |
| Alexion Pharmaceuticals, INC. | $21.42 | 2023 | Strensiq |
| Bayer Healthcare Pharmaceuticals INC. | $20.78 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $20.31 | 2022 | |
| Almatica Pharma LLC | $20.11 | 2024 | Teriparatide |
| Amneal Pharmaceuticals LLC | $18.55 | 2022 | |
| Corcept Therapeutics | $16.50 | 2022 | |
| Kyowa Kirin, INC. | $14.75 | 2023 | Crysvita |
| Tandem Diabetes Care, INC. | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karin Damico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.